PKM and lung carcinoma: mROS can also oxidize the Cys-358 residue of the glycolytic enzyme pyruvate kinase M2 (PKM2) as it has been shown in lung cancer cells, where the oxidation of PKM2 under hypoxia induced an increased pentose phosphate pathway flux, glutathione levels and proliferation [102,103].